Published in Arch Dermatol Res on January 01, 1987
Analysis of T lymphocyte subsets in cytomegalovirus mononucleosis. J Immunol (1981) 3.71
The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. J Immunol (1980) 3.49
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization. J Exp Med (1980) 2.76
Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol (1981) 1.45
Membrane phenotype of murine effector and suppressor T cells involved in delayed hypersensitivity and protective immunity to herpes simplex virus. Cell Immunol (1983) 1.42
Immunity to herpes simplex virus type 2: recurrent lesions are associated with the induction of suppressor cells and soluble suppressor factors. Infect Immun (1983) 1.09
Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections. Infect Immun (1980) 0.91
Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes (Lond) (2006) 3.40
CD3 gamma contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor. EMBO J (1994) 1.54
Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci U S A (1997) 1.47
Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia (1999) 1.45
Regulation and function of the CD3gamma DxxxLL motif: a binding site for adaptor protein-1 and adaptor protein-2 in vitro. J Cell Biol (1997) 1.42
Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells. Leukemia (2001) 1.40
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia (2013) 1.31
Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha. Leukemia (2005) 1.31
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia. Leukemia (2012) 1.27
Management guidelines for the use of alemtuzumab in chronic lymphocytic leukemia. Leukemia (2009) 1.25
Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc Natl Acad Sci U S A (1999) 1.22
MHC class II ligation induces CD58 (LFA-3)-mediated adhesion in human T cells. Exp Clin Immunogenet (1998) 1.10
Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer-aided analysis of data from pigmented skin lesions using digital dermoscopy. Br J Dermatol (2003) 1.09
Malignant Tregs express low molecular splice forms of FOXP3 in Sézary syndrome. Leukemia (2008) 1.07
Role of the T cell receptor ligand affinity in T cell activation by bacterial superantigens. J Biol Chem (2001) 1.05
Regulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome. Leukemia (2011) 1.05
Two distinct pathways exist for down-regulation of the TCR. J Immunol (1998) 1.04
Distinct domains of the CD3-gamma chain are involved in surface expression and function of the T cell antigen receptor. J Biol Chem (1995) 1.02
Role of CD3 gamma in T cell receptor assembly. J Cell Biol (1996) 1.01
Cutting edge: TCR stimulation by antibody and bacterial superantigen induces Stat3 activation in human T cells. J Immunol (1999) 1.01
The role of caspase 3 and BclxL in the action of interleukin 7 (IL-7): a survival factor in activated human T cells. Cytokine (1998) 1.00
Common familial influences on clustering of metabolic syndrome traits with central obesity and insulin resistance: the Kiel obesity prevention study. Int J Obes (Lond) (2006) 1.00
Hypercalcaemia in the accelerated phase of chronic myelogenous leukaemia: no relationship to the phenotype of the blast cells. Scand J Haematol (1985) 0.99
TCRzeta is transported to and retained in the Golgi apparatus independently of other TCR chains: implications for TCR assembly. Eur J Immunol (1999) 0.98
The phosphorylation state of CD3gamma influences T cell responsiveness and controls T cell receptor cycling. J Biol Chem (1998) 0.95
Peptides derived from self-proteins as partial agonists and antagonists of human CD8+ T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35). Cancer Res (1998) 0.95
Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. Br J Cancer (2010) 0.93
Urticaria pigmentosa treated with oral disodium cromoglycate. Dermatologica (1984) 0.93
Monocyte functions in diabetes mellitus. Acta Pathol Microbiol Immunol Scand C (1982) 0.90
Phenotypical and functional characterization of double-negative (CD4-CD8-) alpha beta T-cell receptor positive cells from an immunodeficient patient. Scand J Immunol (1991) 0.89
COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF). Leukemia (2010) 0.89
Molecular characterization of the di-leucine-based internalization motif of the T cell receptor. J Biol Chem (1996) 0.88
A response calculus for immobilized T cell receptor ligands. J Biol Chem (2001) 0.88
COX-2 is a novel target in therapy of mycosis fungoides. Leukemia (2010) 0.88
The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone. Leukemia (2009) 0.88
Interleukin 2 induces a transient downregulation of protein phosphatase 1 and 2A activity in human T cells. Tissue Antigens (1997) 0.87
Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. Br J Dermatol (2014) 0.87
Assembly of the T-cell antigen receptor. Participation of the CD3 omega chain. J Immunol (1993) 0.85
T cell receptor zeta allows stable expression of receptors containing the CD3gamma leucine-based receptor-sorting motif. J Biol Chem (1998) 0.85
A highly conserved phenylalanine in the alpha, beta-T cell receptor (TCR) constant region determines the integrity of TCR/CD3 complexes. Scand J Immunol (1994) 0.85
Acute HTLV-III infection with roseola-like rash. Lancet (1986) 0.84
Consumer available permanent hair dye products cause major allergic immune activation in an animal model. Br J Dermatol (2009) 0.84
Structure of the T cell receptor in a Ti alpha V beta 2, alpha V beta 8-positive T cell line. Eur J Immunol (1994) 0.84
HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur J Cancer (1991) 0.83
Recognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivity. Crit Rev Immunol (1998) 0.83
Gab2 is phosphorylated on tyrosine upon interleukin-2/interleukin-15 stimulation in mycosis-fungoides-derived tumor T cells and associates inducibly with SHP-2 and Stat5a. Exp Clin Immunogenet (2001) 0.82
T cell activation. II. Activation of human T lymphoma cells by cross-linking of their MHC class I antigens. Cell Immunol (1990) 0.81
Lck is involved in interleukin-2 induced proliferation but not cell survival in human T cells through a MAP kinase-independent pathway. Eur Cytokine Netw (2000) 0.81
An enzyme-linked immunosorbent assay for autoantibodies against the nuclear protein Scl-70. J Immunol Methods (1985) 0.81
Recruitment of SHP-1 protein tyrosine phosphatase and signalling by a chimeric T-cell receptor-killer inhibitory receptor. Scand J Immunol (2000) 0.81
Functionally important amino acids in the TCR revealed by immunoselection of membrane TCR-negative T cells. J Immunol (1994) 0.80
In vitro production and characterization of partly assembled human CD3 complexes. Scand J Immunol (2002) 0.80
The bone marrow histological pattern has independent prognostic value in early stage chronic lymphocytic leukaemia. Br J Haematol (1986) 0.80
CHOP versus prednisolone + chlorambucil in chronic lymphocytic leukemia (CLL): preliminary results of a randomized multicenter study. Nouv Rev Fr Hematol (1988) 0.80
Repeated exposure to hair dye induces regulatory T cells in mice. Br J Dermatol (2010) 0.80
beta2-adaptin is constitutively de-phosphorylated by serine/threonine protein phosphatase PP2A and phosphorylated by a staurosporine-sensitive kinase. Biochim Biophys Acta (2000) 0.79
Sister chromatid exchange in patients treated with methotrexate for psoriasis. J Invest Dermatol (1984) 0.79
Aberrations of chromosome 6 in 193 newly diagnosed untreated cases of chronic lymphocytic leukemia. Cancer Genet Cytogenet (1991) 0.79
Protein phosphatase 2A plays a critical role in interleukin-2-induced beta 2-integrin dependent homotypic adhesion in human CD4+ T cell lines. Cytokine (1997) 0.79
Nuclear clefts in chronic lymphocytic leukaemia. A light microscopic and ultrastructural study of a new prognostic parameter. Scand J Haematol (1983) 0.79
Immune responses to hair dyes containing toluene-2,5-diamine. Br J Dermatol (2014) 0.78
Sézary syndrome: phenotypic and functional characterization of the neoplastic cells. Scand J Haematol (1985) 0.78
Structure of the T-cell receptor in a Ti alpha beta, Ti gamma delta double positive T-cell line. Scand J Immunol (1993) 0.78
Interferon-alpha induces transient suppressors of cytokine signalling expression in human T cells. Exp Clin Immunogenet (2001) 0.78
Staphylococcal enterotoxin-A directly stimulates signal transduction and interferon-gamma production in psoriatic T-cell lines. Tissue Antigens (1998) 0.78
Cytoplasmic inclusions in lymphocytes of chronic lymphocytic leukaemia. A report of 10 cases. Virchows Arch A Pathol Anat Histol (1982) 0.77
The phosphatase domains of CD45 are required for ligand induced T-cell receptor downregulation. Scand J Immunol (2000) 0.77
TCR alpha beta chains associate with the plasma membrane independently of CD3 and TCR zeta chains in murine primary T cells. J Immunol (1998) 0.77
Candida Pericarditis in a patients with leukaemia. Scand J Haematol (1981) 0.77
Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support. Leuk Lymphoma (1996) 0.77
Cell markers in lymphoproliferative disease. Lancet (1984) 0.77
T-cell receptor downregulation by ceramide-induced caspase activation and cleavage of the zeta chain. Scand J Immunol (2001) 0.77
Fractionation of T cell subsets on Ig anti-Ig columns: isolation of helper T cells from nonresponder mice, demonstration of antigen-specific T suppressor cells, and selection of CD-3 negative variants of Jurkat T cells. Cell Immunol (1989) 0.77
Ovarian function in young women in long-term remission after treatment for Hodgkin's disease stage I or II. Scand J Haematol (1984) 0.77
Interleukin-2 induces beta2-integrin-dependent signal transduction involving the focal adhesion kinase-related protein B (fakB). Proc Natl Acad Sci U S A (1998) 0.77
Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders. J Intern Med (1999) 0.77
Simultaneous presence of translocations t(14;18) and t(2;8) in a case of chronic lymphocytic leukemia. Cancer Genet Cytogenet (1986) 0.77
Characterization of T cell receptor assembly and expression in a Ti gamma delta-positive cell line. Eur J Immunol (1993) 0.77
[Cholestatic hepatitis during treatment with mexiletine/lidocaine]. Ugeskr Laeger (1984) 0.77
Dapsone in the treatment of cutaneous lupus erythematosus. Dermatologica (1986) 0.76
Influence of molecular weight fractions isolated from roasted malt on the enzyme activities of NADPH-cytochrome c-reductase and glutathione-S-transferase in Caco-2 cells. J Agric Food Chem (2002) 0.76
Priming with r-metHuSCF and filgrastim or chemotherapy and filgrastim in patients with malignant lymphomas: a randomized phase II pilot study of mobilization and engraftment. Bone Marrow Transplant (2010) 0.76
T-cell receptor gamma delta-positive peripheral T-cell lymphomas presenting in the skin: a clinical, histological and immunophenotypic study. Exp Dermatol (1992) 0.76
Chronic lymphocytic leukaemia: a test of a proposed new clinical staging system. Scand J Haematol (1981) 0.76
Discoid lupus erythematosus and carrier status of X-linked chronic granulomatous disease. Dermatologica (1983) 0.75
Lymphocyte subsets in patients with compositae oleoresin dermatitis and increased UVA sensitivity during treatment with azathioprine. Arch Dermatol Res (1985) 0.75
T-cell activation. V. Anti-major histocompatibility complex class I antibody-induced activation and clonal abortion in Jurkat T-leukaemic cells. Immunology (1993) 0.75
Delusions of infestation treated with pimozide: a follow-up study. Acta Derm Venereol (1985) 0.75
[Changes in the serum zinc content after oral administration of zinc and various therapeutic forms]. Wien Klin Wochenschr (1972) 0.75
Chromosome abnormalities in children of mothers 40 years of age or more. A retrospective investigation of a six-year hospital material. Hum Hered (1974) 0.75
[Plasma zinc level in patients with internal, especially hematologic, diseases]. Wien Klin Wochenschr (1972) 0.75
[Carrier materials for biologic tests in electron radiation analysis]. Wien Klin Wochenschr (1971) 0.75
[Chromosome abnormalities in children of elderly mothers. A follow-up study of a hospital material from a 6 year period]. Ugeskr Laeger (1974) 0.75
Metastases from malignant melanoma after laser treatment of undiagnosed pigmented skin lesions. Lasers Med Sci (2013) 0.75
[Distribution of free amino acids in plasma in patients with a chronic lymphatic and acute leukemia]. Wien Klin Wochenschr (1971) 0.75
[Actinomycosis (cervico-facial form)]. Hautarzt (1973) 0.75
[Effect of methodical variations on the standard curves in vitamin B12 determinations with Lactobacillus leichmannii]. Pathol Microbiol (Basel) (1970) 0.75